4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-032252
President and CEO sold 22,880 shares at an average $52.40 ($1,198,818)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2026-03-17 | Sale 10b5-1 | −5,280 | $51.66 | $272,760 | 90,920 | I |
| BENDHEIM JACK President and CEO | 2026-03-18 | Sale 10b5-1 | −4,311 | $51.80 | $223,301 | 86,609 | I |
| BENDHEIM JACK President and CEO | 2026-03-18 | Sale 10b5-1 | −3,598 | $53.03 | $190,819 | 83,011 | I |
| BENDHEIM JACK President and CEO | 2026-03-18 | Sale 10b5-1 | −2,651 | $53.64 | $142,209 | 80,360 | I |
| BENDHEIM JACK President and CEO | 2026-03-19 | Sale 10b5-1 | −1,939 | $51.78 | $100,409 | 78,421 | I |
| BENDHEIM JACK President and CEO | 2026-03-19 | Sale 10b5-1 | −4,977 | $52.79 | $262,718 | 73,444 | I |
| BENDHEIM JACK President and CEO | 2026-03-19 | Sale 10b5-1 | −124 | $53.24 | $6,602 | 73,320 | I |
| Open-market sales · 22,880 sh · avg $52.40 · $1,198,818 | |||||||
Loading xslF345X06/tm269323-1_4seq1.xml…